Science advances

How plants produce psychedelic tryptamines using complete natural pathways from three life groups

Updated

Abstract

Essence

The paper rebuilds DMT-related psychedelic biosynthesis in plants as a production and diversification platform.

Evidence

A plant metabolic-engineering platform experiment reconstructed pathways for psilocin, psilocybin, DMT, bufotenin, 5-methoxy-DMT, and halogenated analogs.

Caveat

The abstract reports biosynthesis and enzyme-engineering performance, not therapeutic activity, safety, or clinical usefulness of the products.

Simplified

Full Text

We can’t show the full text here under this license.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free